Neglect of relevant treatment recommendations in the conduct and reporting of a laser therapy knee osteoarthritis trial: letter to the editor by Stausholm, Martin Bjørn & Bjordal, Jan Magnus
CORRESPONDENCE Open Access
Neglect of relevant treatment
recommendations in the conduct and
reporting of a laser therapy knee
osteoarthritis trial: letter to the editor
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Abstract
We read with interest the article by Gomes et al. entitled: “Exercise program combined with electrophysical modalities
in subjects with knee osteoarthritis: A randomised, placebo-controlled clinical trial”. Gomes et al. concluded that the
low-level laser therapy (LLLT) did not reduce knee osteoarthritis pain when applied as an adjunct to exercise
therapy. We argue that Gomes et al. neglected relevant laser treatment recommendations in the conduct and
reporting of the trial.
Gomes et al. did not state the Joules per treatment spot applied. We calculated the Joules applied from other laser
information in the report and found that it is too low of a dose according to the World Association for Laser
Therapy (WALT) guidelines. Furthermore, we have published a meta-analysis of 22 placebo-controlled trials
demonstrating a significant difference in pain-relieving effect between doses in adherence and non-adherence to
the WALT guidelines. However, neither the WALT guidelines, nor our meta-analysis was mentioned by Gomes et al.
Moreover, Gomes et al. did not state whether the output power of the laser device was measured, and this is
concerning because in the city of São Paulo, where the trial was conducted, most laser devices have been found to
deliver less of a dose than specified by the manufacturers.
In summary, we found that the best available evidence regarding effective and ineffective LLLT dosing from
systematic reviews was neglected in the conduct and reporting of the trial, and that the laser device may not have
been calibrated.
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We read with interest the article by Gomes et al. enti-
tled: “Exercise program combined with electrophysical
modalities in subjects with knee osteoarthritis: A rando-
mised, placebo-controlled clinical trial”. Gomes et al.
concluded that the addition of low-level laser therapy
(LLLT) “… did not increase the clinical benefit after 8
weeks of treatment (primary and secondary variables)
when combined with an exercise protocol for knee osteo-
arthritis.” [1].
We argue that the results of the trial were not inter-
preted in the light of what was already known in terms
of LLLT dosing.
We are surprised that Gomes et al. did not state the
Joules per treatment spot applied [1] since this has been
found to be a crucial factor in LLLT [2–4]. However,
this dose parameter can be calculated from other LLLT
information in the report. Gomes et al. stated that a 904
nm wavelength laser device with a probe (spot) size of
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0.1309 cm2 was utilized in skin contact mode and that
the energy density was 6 J/cm2 [1]. This means that the
dose per treatment spot applied was 0.78 J (6 J/
cm2*0.1309 cm2 = 0.78 J).
In the World Association for Laser Therapy (WALT)
dose guidelines, irradiating the osteoarthritic knee with
at least 1 J of 904 nm wavelength laser per treatment
spot is recommended [5]. Our research group has pub-
lished a systematic review and meta-analysis with 22
placebo-controlled trials on the topic. Here, we initially
found that pain was overall significantly reduced by
LLLT compared to placebo-control. Subsequently, we
sub-grouped the trials using the WALT recommenda-
tions for LLLT dose per treatment spot and this revealed
a significant dose-response relationship; the pain-relief
provided by the recommended LLLT doses was highly
significantly superior to placebo even at follow-up 12
weeks post-therapy, and the difference was greater than
20mm on the 0–100mm visual analogue scale from the
final 4–8 weeks of therapy through follow-ups 6–8 weeks
post-therapy. Importantly, we found that 904 nm wave-
length laser doses recommended against by WALT
(lower than 1 J per treatment spot) provide no or little
positive effect in knee osteoarthritis [3].
The dose applied by Gomes et al. does not satisfy the
WALT recommendations and our LLLT dose-response
meta-analysis can explain the negative findings. How-
ever, neither the WALT recommendations [5], nor our
systematic review [3] is mentioned by Gomes et al. [1].
Gomes et al. claimed that they used a similar dose to
that applied by Hegedus et al. However, Hegedus et al.
stated that they applied 6 J per treatment spot, not 6 J/
cm2 [6]. It is important to understand that J/cm2 is
equivalent to J per treatment spot only in instances
where the laser beam covers exactly 1 cm2, which it
rarely does.
Gomes et al. did not state whether the output power
of the laser device was measured. It is a major concern
that in the greater São Paulo area of Brazil, where the
study by Gomes et al. was conducted, 59 of 60 laser de-
vices tested delivered less of a dose than specified by the
manufacturers [7]. We conclude that is very likely that
the dose used in this study is ineffective.
In summary, we found that the best available evidence
regarding effective and ineffective LLLT dosing from
other trials was neglected in the conclusion by Gomes
et al. and that their laser device probably was not tested
and most likely delivered an ineffective dose.
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